Search
Akari Therapeutics PLC
AKTXAdd to Watchlist
7.370USD
-0.380-4.90%
Close 11-06 16:00（ET）
16.84MMarket Cap
LossP/E TTM
Today
-4.90%
5 Days
-10.56%
1 Month
-12.16%
6 Months
+26.63%
Year to Date
-36.25%
1 Year
-70.09%
Key Figures
7.770Open
9.025High
233.00Volume
LossP/E TTM
LossP/E Dynamic
--Dividend TTM
0.01%Turnover Ratio
7.750Prev. Close
7.460Low
1.77KTurnover
LossP/E Static
0.92P/B
0.00%Div Yield TTM
-66.11%ROA
29.32052wk High
0.01Volume Ratio
-19.79MNet Profit
2.29MShares
-15.4400EPS TTM
1.47Beta
-155.28%ROE
4.80052wk Low
20.19%Amplitude
--Gross Margin
16.84MMarket Cap
-2.67Reward/Risk
263.49%Risk Rate
Analyst Rating
Akari Therapeutics PLC Technical Analysis
Technical Indicators
Strong sell
Summary
Strong sell
Moving Average
Strong sell
Financial Indicators
Relevant data have not been disclosed by the company yet.
Relevant data have not been disclosed by the company yet.
Earnings
Next reporting date
--
Reporting Period
2026Q2
Earnings / Forecast
-2.40/-1.28
Revenue / Forecast
--/0.00
Akari Therapeutics PLC Profile
SectorPharmaceuticals
Ticker SymbolAKTX
Number of employees8
CountryUnited States of America
Ownership
| Shareholders | Proportion |
|---|---|
| Huh (Hoyoung) | 10.26% |
| Patel (Samir Rashmikant) | 6.93% |
| Prudo-Chlebosz (Raymond) | 6.56% |
| Armistice Capital LLC | 5.95% |
| Shareholder Types | Proportion |
|---|---|
| Individual Investor | 24.55% |
| Hedge Fund | 6.27% |
| Investment Advisor/Hedge Fund | 1.80% |
| Family Office | 0.65% |
Related Instruments
-0.79%
+1.43%
+1.07%
-0.14%
+0.38%
-0.22%
+0.03%
-0.41%
+0.02%
-0.20%
+0.85%
-1.57%
-1.04%
+0.28%
+5.27%
-0.16%
+0.16%
-0.80%
+1.46%
+3.63%Popular Instruments
51290.600
-208.500 (-0.41%)
26964.500
+329.300 (+1.24%)
7380.000
+23.100 (+0.31%)
12797.000
-1.000 (-0.01%)
58142.000
+876.000 (+1.53%)
6140.600
-37.200 (-0.60%)
89.857
-0.176 (-0.20%)
342.370
-1.800 (-0.52%)
186.640
+5.040 (+2.78%)
4065.670
-33.020 (-0.81%)
FAQs
What is the current price of Akari Therapeutics PLC (AKTX)?
The current price of Akari Therapeutics PLC (AKTX) is 7.37.
What is the symbol of Akari Therapeutics PLC?
The ticker symbol of Akari Therapeutics PLC is AKTX.
What is the 52-week high of Akari Therapeutics PLC?
The 52-week high of Akari Therapeutics PLC is 29.32.
What is the 52-week low of Akari Therapeutics PLC?
The 52-week low of Akari Therapeutics PLC is 4.80.
What is the market capitalization of Akari Therapeutics PLC?
The market capitalization of Akari Therapeutics PLC is 16.84M.
Is Akari Therapeutics PLC (AKTX) currently rated as Buy, Hold, or Sell?
According to analysts, Akari Therapeutics PLC (AKTX) has an overall rating of Buy, with a price target of 29.12.
What is the Earnings Per Share (EPS TTM) of Akari Therapeutics PLC (AKTX)?
The Earnings Per Share (EPS TTM) of Akari Therapeutics PLC (AKTX) is -15.44.